How common are myeloproliferative neoplasms? A systematic review and meta-analysis

Guideline for the diagnosis and management of myelofibrosis

(2012) John T. Reilly et al.   BRITISH JOURNAL OF HAEMATOLOGY

Incidence, survival and prevalence of myeloid malignancies in Europe

(2012) O. Visser et al.   EUROPEAN JOURNAL OF CANCER

Global estimates of cancer prevalence for 27 sites in the adult population in 2008

(2012) Freddie Bray et al.   INTERNATIONAL JOURNAL OF CANCER

Improving Survival Trends in Primary Myelofibrosis: An International Study

(2012) Francisco Cervantes et al.   JOURNAL OF CLINICAL ONCOLOGY

Environmental, lifestyle, and familial/ethnic factors associated with myeloproliferative neoplasms

(2011) Lesley A. Anderson et al.   AMERICAN JOURNAL OF HEMATOLOGY

Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network

(2011) A Smith et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms

(2011) Magnus Björkholm et al.   JOURNAL OF CLINICAL ONCOLOGY

Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms

(2010) S. T. Oh et al.   BLOOD

Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

(2010) M. Sant et al.   BLOOD

Guideline for investigation and management of adults and children presenting with a thrombocytosis

(2010) Claire N. Harrison et al.   BRITISH JOURNAL OF HAEMATOLOGY

Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias

(2010) O. Abdel-Wahab et al.   CANCER RESEARCH

Incidence of polycythemia vera in a defined population

(2010) Stig Berglund et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria

(2010) Martha Wadleigh et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1

(2010) A Tefferi   LEUKEMIA

Childhood leukemia incidence in Brazil according to different geographical regions

(2010) Rejane de Souza Reis et al.   PEDIATRIC BLOOD & CANCER

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study

(2009) F. Girodon et al.   HAEMATOLOGICA

Épidémiologie des hémopathies malignes en Basse-Normandie

(2009) X. Troussard et al.   REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE

Prevalence of polycythemia vera and essential thrombocythemia

(2008) Xiaomei Ma et al.   AMERICAN JOURNAL OF HEMATOLOGY

Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs

(2008) D. E. Rollison et al.   BLOOD

Cancer registration in developing countries: luxury or necessity?

(2008) Maria Grazia Valsecchi et al.   LANCET ONCOLOGY

Genetic complexity of myeloproliferative neoplasms

(2008) R Kralovics   LEUKEMIA

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

(2008) M Rohrbacher et al.   LEUKEMIA

Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies

(2007) Jitka Veselovska et al.   LEUKEMIA RESEARCH